<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Invion Ltd — News on 6ix</title>
    <link>https://6ix.com/company/invion-ltd</link>
    <description>Latest news and press releases for Invion Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 30 Apr 2026 06:01:04 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/invion-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683665bc78dffbe2df15da8a.webp</url>
      <title>Invion Ltd</title>
      <link>https://6ix.com/company/invion-ltd</link>
    </image>
    <item>
      <title>Appendix 4C and Quarterly Activities Report - March 2026</title>
      <link>https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-march-2026-1</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-march-2026-1</guid>
      <pubDate>Thu, 30 Apr 2026 06:01:04 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activities Report - March 2026</description>
    </item>
    <item>
      <title>Skin Cancer Trial Moves to BCC With More Encouraging Signals</title>
      <link>https://6ix.com/company/invion-ltd/news/skin-cancer-trial-moves-to-bcc-with-more-encouraging-signals</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/skin-cancer-trial-moves-to-bcc-with-more-encouraging-signals</guid>
      <pubDate>Tue, 21 Apr 2026 04:07:04 GMT</pubDate>
      <description>Skin Cancer Trial Moves to BCC With More Encouraging Signals</description>
    </item>
    <item>
      <title>Appendix 4D and Half Year Financial Report</title>
      <link>https://6ix.com/company/invion-ltd/news/appendix-4d-and-half-year-financial-report-97</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/appendix-4d-and-half-year-financial-report-97</guid>
      <pubDate>Fri, 27 Feb 2026 03:53:26 GMT</pubDate>
      <description>Appendix 4D and Half Year Financial Report</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activities Report - December 2025</title>
      <link>https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-december-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-december-2025</guid>
      <pubDate>Fri, 30 Jan 2026 12:39:13 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activities Report - December 2025</description>
    </item>
    <item>
      <title>Major Shareholders Lead Invion $1.3M Capital Raise</title>
      <link>https://6ix.com/company/invion-ltd/news/major-shareholders-lead-invion-dollar13m-capital-raise</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/major-shareholders-lead-invion-dollar13m-capital-raise</guid>
      <pubDate>Fri, 30 Jan 2026 12:35:10 GMT</pubDate>
      <description>Major Shareholders Lead Invion $1.3M Capital Raise</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/invion-ltd/news/trading-halt-1068</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/trading-halt-1068</guid>
      <pubDate>Thu, 29 Jan 2026 04:20:07 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Pause in Trading</title>
      <link>https://6ix.com/company/invion-ltd/news/pause-in-trading-723</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/pause-in-trading-723</guid>
      <pubDate>Thu, 29 Jan 2026 04:05:11 GMT</pubDate>
      <description>Pause in Trading</description>
    </item>
    <item>
      <title>Hanlim &amp; Korean Government Fund Pathway to Clinical Trial</title>
      <link>https://6ix.com/company/invion-ltd/news/hanlim-and-korean-government-fund-pathway-to-clinical-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/hanlim-and-korean-government-fund-pathway-to-clinical-trial</guid>
      <pubDate>Tue, 23 Dec 2025 03:58:14 GMT</pubDate>
      <description>Hanlim &amp; Korean Government Fund Pathway to Clinical Trial</description>
    </item>
    <item>
      <title>Invion Secures Expanded Photosoft Global Exclusive License</title>
      <link>https://6ix.com/company/invion-ltd/news/invion-secures-expanded-photosoft-global-exclusive-license</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/invion-secures-expanded-photosoft-global-exclusive-license</guid>
      <pubDate>Wed, 03 Dec 2025 03:04:15 GMT</pubDate>
      <description>Invion Secures Expanded Photosoft Global Exclusive License</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activities Report - September 2025</title>
      <link>https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-september-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-september-2025</guid>
      <pubDate>Fri, 31 Oct 2025 02:35:14 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activities Report - September 2025</description>
    </item>
    <item>
      <title>Funded Collaboration Agreement with Protect Animal Health</title>
      <link>https://6ix.com/company/invion-ltd/news/funded-collaboration-agreement-with-protect-animal-health</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/funded-collaboration-agreement-with-protect-animal-health</guid>
      <pubDate>Tue, 21 Oct 2025 03:03:16 GMT</pubDate>
      <description>Funded Collaboration Agreement with Protect Animal Health</description>
    </item>
    <item>
      <title>Repayment of Lind Facility with Successful Capital Raise</title>
      <link>https://6ix.com/company/invion-ltd/news/repayment-of-lind-facility-with-successful-capital-raise</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/repayment-of-lind-facility-with-successful-capital-raise</guid>
      <pubDate>Fri, 10 Oct 2025 03:26:04 GMT</pubDate>
      <description>Repayment of Lind Facility with Successful Capital Raise</description>
    </item>
    <item>
      <title>Response to ASX Aware Letter</title>
      <link>https://6ix.com/company/invion-ltd/news/response-to-asx-aware-letter-94</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/response-to-asx-aware-letter-94</guid>
      <pubDate>Thu, 28 Aug 2025 03:32:50 GMT</pubDate>
      <description>Response to ASX Aware Letter</description>
    </item>
    <item>
      <title>Appendix 4E and Annual Report</title>
      <link>https://6ix.com/company/invion-ltd/news/appendix-4e-and-annual-report-122</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/appendix-4e-and-annual-report-122</guid>
      <pubDate>Wed, 27 Aug 2025 05:16:15 GMT</pubDate>
      <description>Appendix 4E and Annual Report</description>
    </item>
    <item>
      <title>Response to ASX Price Query</title>
      <link>https://6ix.com/company/invion-ltd/news/response-to-asx-price-query-386</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/response-to-asx-price-query-386</guid>
      <pubDate>Wed, 20 Aug 2025 04:10:14 GMT</pubDate>
      <description>Response to ASX Price Query</description>
    </item>
    <item>
      <title>Orphan Drug Designation Granted by U.S. FDA For Anal Cancer</title>
      <link>https://6ix.com/company/invion-ltd/news/orphan-drug-designation-granted-by-us-fda-for-anal-cancer</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/orphan-drug-designation-granted-by-us-fda-for-anal-cancer</guid>
      <pubDate>Wed, 20 Aug 2025 04:10:12 GMT</pubDate>
      <description>Orphan Drug Designation Granted by U.S. FDA For Anal Cancer</description>
    </item>
    <item>
      <title>Appendix 4C and Quarterly Activities Report - June 2025</title>
      <link>https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-june-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/appendix-4c-and-quarterly-activities-report-june-2025</guid>
      <pubDate>Thu, 31 Jul 2025 08:44:15 GMT</pubDate>
      <description>Appendix 4C and Quarterly Activities Report - June 2025</description>
    </item>
    <item>
      <title>Security Class Reinstatement to Quotation</title>
      <link>https://6ix.com/company/invion-ltd/news/security-class-reinstatement-to-quotation-17</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/security-class-reinstatement-to-quotation-17</guid>
      <pubDate>Thu, 17 Jul 2025 10:28:10 GMT</pubDate>
      <description>Security Class Reinstatement to Quotation</description>
    </item>
    <item>
      <title>Security Class Suspension from Quotation</title>
      <link>https://6ix.com/company/invion-ltd/news/security-class-suspension-from-quotation-18</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/security-class-suspension-from-quotation-18</guid>
      <pubDate>Fri, 11 Jul 2025 03:34:16 GMT</pubDate>
      <description>Security Class Suspension from Quotation</description>
    </item>
    <item>
      <title>Underwritten Loyalty Option Entitlement Offer Prospectus</title>
      <link>https://6ix.com/company/invion-ltd/news/underwritten-loyalty-option-entitlement-offer-prospectus</link>
      <guid isPermaLink="true">https://6ix.com/company/invion-ltd/news/underwritten-loyalty-option-entitlement-offer-prospectus</guid>
      <pubDate>Mon, 23 Jun 2025 04:02:14 GMT</pubDate>
      <description>Underwritten Loyalty Option Entitlement Offer Prospectus</description>
    </item>
  </channel>
</rss>